- On December 31, 2007 during President Bush's second term
- On March 6, 2009, very early in President Obama's first term, which was their lowest point due to the spillover effects resulting from the 2008 financial meltdown, and
- also on the most recent date February 5, 2014.
The historical common stock prices of these companies were obtained from the following two excellent internet resources.... Google Finance and MarketWatch Big Charts.
These 19 US Other Drug Manufacturers had their average stock prices drop by a huge 51% from December 31, 2007 during President Bush's second Presidential term, to March 6, 2009, very early in President Obama's first term, which was the very lowest point for the overall stock market due to the spillover effects resulting from the disastrous 2008 Financial Meltdown.
But in the slightly less than five years since March 6, 2009, the average stock prices of these same 19 US Other Drug Manufacturers have increased by a spectacular 1,096% through February 5, 2014.
The main driver of this 1,096% average stock price growth was Pharmacyclics, a clinical-stage biopharmaceutical company focusing on cancer drugs. Pharmacyclics had its stock price advance by an incredible 14,647% since March 6, 2009.
Clearly, the investors in and employees of these 19 US Other Drug Manufacturers must be extremely pleased with the impact of actions taken by both the Obama Administration and the US Fed to successfully rescue the US economy from its extremely weakened state.
Also, these Drug Manufacturers have flat out thrived under the Affordable Care Act. Wise investors have moved up their common stock market prices smartly in anticipation of many more US citizens being covered by insurance and by Medicaid Expansion.
Nine of these 19 Other Drug Manufacturers are based in California. All 19 of them are based in US States voting for Barack Obama for President in 2008.
Below here are the stock market prices of each of these 19 US Other Drug Manufacturers on February 5, 2014, on March 6, 2009, and on December 31, 2007:
| Market | Market | ||||||
| Price | Price | ||||||
| % | % | ||||||
| Change | Change | ||||||
| Market | Market | Market | 3-6-09 | 12-31-07 | |||
| Price | Price | Price | to | to | |||
| US Other Drug Manufacturers | 2-5-14 | 3-6-09 | 12-31-07 | 2-5-14 | 3-6-09 | ||
| Pharmacyclics | Sunnyvale | CA | 126.81 | 0.86 | 1.45 | 14647% | -41% |
| Protalex | Summit | NJ | 8.95 | 0.40 | 6.50 | 2138% | -94% |
| Lannett Company | Philadelphia | PA | 32.53 | 5.38 | 3.09 | 505% | 74% |
| DepoMed | Newark | CA | 11.93 | 2.12 | 3.26 | 463% | -35% |
| Elite Pharmaceuticals | Northvale | NJ | 0.26 | 0.05 | 2.16 | 430% | -98% |
| Cubist Pharmaceuticals | Lexington | MA | 70.08 | 14.67 | 20.51 | 378% | -28% |
| SciClone Pharmaceuticals | Foster City | CA | 4.37 | 1.08 | 2.06 | 305% | -48% |
| Endo Health Solutions | Malvern | PA | 68.65 | 17.11 | 26.67 | 301% | -36% |
| Isis Pharmaceuticals | Carlsbad | CA | 46.83 | 12.13 | 15.75 | 286% | -23% |
| The Medicines Company | Parsippany | NJ | 33.04 | 9.33 | 19.16 | 254% | -51% |
| Forest Laboratories | New York | NY | 66.78 | 19.12 | 36.45 | 249% | -48% |
| Allergan | Irvine | CA | 115.20 | 36.52 | 64.24 | 215% | -43% |
| Dynavax Technologies | Berkeley | CA | 1.69 | 0.55 | 5.11 | 208% | -89% |
| United Therapeutics | Silver Spring | MD | 96.04 | 31.48 | 48.83 | 205% | -36% |
| Orexigen Therapeutics | La Jolla | CA | 6.57 | 2.63 | 14.25 | 150% | -82% |
| Sucampo Pharmaceuticals | Bethesda | MD | 7.60 | 4.38 | 18.34 | 74% | -76% |
| POZEN | Chapel Hill | NC | 7.47 | 4.99 | 12.00 | 50% | -58% |
| DURECT | Cupertino | CA | 1.92 | 1.54 | 6.43 | 25% | -76% |
| MEI Pharma | San Diego | CA | 8.21 | 21.00 | 173.40 | -61% | -88% |
| Average % Change all 19 | 1096% | -51% |
